Literature DB >> 923023

Intravascular platelet aggregation and acute respiratory insufficiency.

J Vaage.   

Abstract

Respiratory effects of long-lasting episodes of intravascular platelet aggregation have been studied in cats. Animals in 1 group had the chest opened and were given mechanical ventilation with a constant tidal volume. Animals of another group were breathing spontaneously. Platelet aggregation was induced by intravenous infusion (for 1 hr) of a suspension of collagen fibrils. Such infusions caused acute respiratory distress in both groups. Severe arterial hypoxemia and rapid breathing as well as constriction of airways and lung vessels occurred. Most of these changes were reversed within 2 hr after collagen infusion had ended. Deep lung inflations markedly improved lung function. It is concluded that an acute, but reversible pulmonary insufficiency might be caused by pulmonary microembolization due to intravascular platelet aggregation. The arterial hypoxemia is suggested to be caused by disturbances in the ventilation-perfusion ratio secondary to airway constriction and closure. The present findings also imply that besides platelet aggregation, some additional factors are necessary for irreversible or progressive respiratory insufficiency to develop.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 923023

Source DB:  PubMed          Journal:  Circ Shock        ISSN: 0092-6213


  3 in total

Review 1.  Cellular and humoral mediators of pulmonary edema.

Authors:  A B Malik; W M Selig; K E Burhop
Journal:  Lung       Date:  1985       Impact factor: 2.584

2.  Role of serotonin in patients with acute respiratory failure.

Authors:  W V Huval; S Lelcuk; D Shepro; H B Hechtman
Journal:  Ann Surg       Date:  1984-08       Impact factor: 12.969

3.  Severity of multiple organ failure (MOF) but not of sepsis correlates with irreversible platelet degranulation.

Authors:  M Gawaz; S Fateh-Moghadam; G Pilz; H J Gurland; K Werdan
Journal:  Infection       Date:  1995 Jan-Feb       Impact factor: 3.553

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.